L-NORVALIN AND ISCHEMICAL PRECONDITIONING ACTION MECHANISMS ANALYSIS AT LIVER ISCHEMIA/REPERFUSION

Abstract

In this article ischemical preconditioning and L-norvalin efficacy and mechanisms of action pharmacological analysis at liver experimental ischemia/reperfusion were made. During investigation ischemical preconditioning high effectiveness totally wasn’t blocked by glibenclamide showed. L-norvaline also showed marked hepatoprotective effect abolished by glibenclamide just partly.

References

  1. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research / R. Bolli // J. Mol. Cell. Cardiol. - 2001. - Vol. 33. -Р. 1897-1918.
  2. Cohen, M.V. Adenosine: trigger and mediator of cardioprotection / M.V. Cohen, J.M. Downey // Basic. Res. Cardiol. -2008. - Vol. 103, № 3. - P. 203-215.
  3. Downey J.M. Signaling pathways in ischemic preconditioning / J.M. Downey, A.M. Davis, M.V. Cohen // Heart. Fail. Rev. - 2007. - Vol. 12. - P. 181-188.
  4. Kirino T. Ischemic tolerance / T. Kirino // J. Cerebr. Blood. Flow. Metabol. - 2002. - Vol. 22. - P. 1283-1296.
  5. Murry C.E. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium / С.Е. Murry, R.B. Jennings, К.А. Reimer // Circulation. -1986. - Vol. 14. - Р. 1124-1136.
  6. Rezkalla S.H. Preconditioning in humans / S.H. Rezkalla, R.A. Kloner // Heart. Fail. Rev. - 2007. - Vol. 12. - P. 201-206.
  7. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis / Ran Meng [et al.] // Neurology. -2012. - Vol. 79. - P. 1853-1861.

Copyright (c) 2013 Pokrovsky M.V., Lopatin D.V., Alehin S.A., Kolmykov D.I., Ivanova L.V., Lucenko V.D., Speransky S.L., Suhoterin I.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies